Skip to main content

Table 1 Clinical characteristics of neuroblastoma patients and tumor tissues.

From: Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma

Patient

Sex

Age [months]

Stage

Differentiation

n-myc

1p del

ploidy

PHOX2B

ALK

1

F

31

4

u.d.

neg

neg

2n

neg

n.c.

2

M

3

2A

u.d.

neg

neg

3n

neg

n.c.

3

M

3

4S

u.d.

neg

neg

3n

neg

n.c.

4

M

11

1

u.d.

neg

neg

3n

neg

n.c.

5

M

11

2B

u.d.

pos

pos

3n/4n

neg

n.c.

6

M

15

2B

u.d.

neg

neg

3n

neg

n.c.

7

F

142

4

u.d.

neg

neg

3n

neg

neg

8

F

1

3

u.d.

neg

neg

3n

neg

neg

9

M

7

3A

u.d.

neg

neg

3n

neg

n.c.

10

F

10

4S

p.d.

neg

neg

2n

neg

n.c.

11

M

11

1

u.d.

neg

n.d.

n.d.

neg

neg

12

F

166

4

u.d.

neg

neg

3n

neg

neg

13

M

2

1

u.d.

neg

neg

n.d

neg

n.c.

14

M

5

1

u.d.

neg

neg

3n

neg

n.c.

  1. u.d.: undifferentiated; p.d.: poorly differentiated; n.d.: not determined; n-myc neg: no n-myc amplification; n-myc pos: n-myc amplification; PHO2B neg: no mutation; ALK neg: no ALK mutation, n.c.: no cDNA available